Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to -$0.91.

  • ENvue Medical's EPS (Basic) rose 7443.82% to -$0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.85, marking a year-over-year increase of 7827.83%. This contributed to the annual value of -$13.73 for FY2024, which is 4113.44% up from last year.
  • As of Q3 2025, ENvue Medical's EPS (Basic) stood at -$0.91, which was up 7443.82% from -$1.03 recorded in Q2 2025.
  • ENvue Medical's EPS (Basic)'s 5-year high stood at $2.38 during Q1 2024, with a 5-year trough of -$27.18 in Q2 2024.
  • For the 5-year period, ENvue Medical's EPS (Basic) averaged around -$2.78, with its median value being -$0.91 (2025).
  • Per our database at Business Quant, ENvue Medical's EPS (Basic) crashed by 920000.0% in 2022 and then soared by 45522.39% in 2024.
  • ENvue Medical's EPS (Basic) (Quarter) stood at -$1.96 in 2021, then rose by 26.03% to -$1.45 in 2022, then crashed by 252.32% to -$5.11 in 2023, then fell by 3.78% to -$5.3 in 2024, then surged by 82.84% to -$0.91 in 2025.
  • Its EPS (Basic) was -$0.91 in Q3 2025, compared to -$1.03 in Q2 2025 and -$3.98 in Q1 2025.